The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment
Crossref DOI link: https://doi.org/10.1007/s00595-016-1464-8
Published Online: 2017-01-06
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tokunaga, Ryuma
Sakamoto, Yasuo
Nakagawa, Shigeki
Yoshida, Naoya
Baba, Hideo
License valid from 2017-01-06